SCHEMBL2660052

SCHEMBL2660052

COC(=O)CN1CCC(c2cccc(Nc3ccc(C(=O)OCCO)cc3[N+](=O)[O-])c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.44
MAPT P10636 7/20 0.44
HPGD P15428 3/20 0.44
ALDH1A1 P00352 5/20 0.41
SLC2A1 P11166 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
AKR1C4 P17516 2/20 0.40
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
AKR1C1 Q04828 2/20 0.40
RAB9A P51151 2/20 0.40
PTGER4 P35408 1/20 0.40
AKR1B10 O60218 1/20 0.40
AKR1B1 P15121 1/20 0.40
LMNA P02545 2/20 0.39
RECQL P46063 1/20 0.39
HCAR3 P49019 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2650240 0.94 MAPT (0.44) THRBMAPTHPGDALDH1A1SLC2A1
SCHEMBL2661269 0.87 NPC1 (0.41) PTGER4NPC1GAA
SCHEMBL2661874 0.86 MAPT (0.46) THRBMAPTHPGDALDH1A1AKR1C4
SCHEMBL5780492 0.84 MAPT (0.46) THRBMAPTHPGDALDH1A1SLC2A1
SCHEMBL2652875 0.82 THRB (0.47) THRBMAPTHPGDALDH1A1SLC2A1
SCHEMBL2661830 0.81 MAPT (0.45) THRBMAPTHPGDALDH1A1AKR1C4
SCHEMBL2662423 0.80 LMNA (0.48) THRBMAPTHPGDALDH1A1RAB9A
SCHEMBL2662596 0.77 MAPT (0.42) THRBMAPTHPGDALDH1A1SMN1; SMN2
SCHEMBL2661601 0.76 MAPT (0.47) THRBMAPTHPGDALDH1A1AKR1C4
SCHEMBL4702845 0.76 MAPT (0.46) THRBMAPTHPGDALDH1A1SLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002050057-A1 NOVEL BENZIMIDAZOLE DERIVATIVES FOR THE TREATMENT OF GABA-ALPHA MEDIATED DISORDERS NEUROSEARCH A/S (DK) 2002-06-27 WO disclosed